葵花药业：子公司小儿肺热咳喘口服液药物临床试验获批准

Core Viewpoint - The company has received approval from the National Medical Products Administration for clinical trials of a pediatric medication aimed at treating acute bronchitis in children [1] Company Summary - The company,葵花药业, announced that its wholly-owned subsidiary, 黑龙江葵花药业股份有限公司, has obtained a clinical trial approval notice for its pediatric medication, 小儿肺热咳喘口服液 [1]